| 1. |
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis[J]. Endocr Rev, 2000, 21(2): 115-137.
|
| 2. |
Gali JC. Osteoporose[J]. Acta Ortop Bras, 2001, 9(6): 53-62.
|
| 3. |
Birkedal-Hansen EL. Role of matrix rnetalloproteinases in human periodontal diseases[J]. J Periodontol, 1993, 64(10): 474-484.
|
| 4. |
Altman RD. Criteria for classification of clinical osteoarthritis[J]. J Rheumatol, 1991, 18(9): 10-12.
|
| 5. |
徐苓. 骨質疏松癥[M]. 上海: 上海科學技術出版社, 2011: 63.
|
| 6. |
Scotti C, Piccinini E, Takizawa H, et al. Engineering of a functional bone organ through endochondral ossification[J]. Proc Natl Acad Sci USA, 2013, 110(10): 3997-4002.
|
| 7. |
Sanchez C, Pesesse L, Gabay O, et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression[J]. Arthritis Rheum, 2012, 64(4): 1193-1203.
|
| 8. |
Hirata M, Kugimiya F, Fukai A, et al. C/EBPβ and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2α as the inducer in chondrocytes[J]. Hum Mol Genet, 2012, 21(5): 1111-1123.
|
| 9. |
Wu MH, Lo JF, Kuo CH, et al. Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways[J]. J Cell Physiol, 2012, 227(8): 3016-3026.
|
| 10. |
Pecchi E, Priam S, Mladenovic Z, et al. A potential role of chondroitin sulfate on bone in osteoarthritis:inhibition of prostaglandin E2 and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts[J]. Osteoarthr Cartilage, 2012, 20(2): 127-135.
|
| 11. |
Kusano K, Miyaura C, Inada M, et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption[J]. Endocrinology, 1998, 139(3): 1338-1345.
|
| 12. |
DAI Y. Relationships between circulating matrix metallproteinase-3, tissue inhibitor of matrix metalloproteinase-1 levels and postmenopausal osteoporosis[J]. Bone, 2010, 47(S3): 389-390.
|
| 13. |
Yamagata K, Li X, Ikegaki S, et al. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression[J]. J Biol Chem, 2012, 287(2): 1588-1599.
|
| 14. |
Patil A, Sable R, Kothari R. Genetic expression of MMP-Matrix-mettalo-proteinases (MMP-1 and MMP-13) as a function of anterior mandibular repositioning appliance on the growth of mandibular condylar cartilage with and without administration of insulin like growth factor (IGF-1) and transforming growth factor-B (TGF-β)[J]. Angle Orthod, 2012, 82(6): 1053-1059.
|
| 15. |
Schmucker AC, Wright JB, Cole MD, et al. Distal interleukin-1β (IL-1β) response element of human matrix metalloproteinase-13 (MMP-13) binds activator protein 1 (AP-1) transcription factors and regulates gene expression[J]. J Biol Chem, 2012, 287(2): 1189-1197.
|
| 16. |
Barthelemi S, Robinet J, Garnotel R, et al. Mechanical forces-induced human osteoblasts differentiation involves MMP-2/MMP-13/MT1-MMP proteolytic cascade[J]. J Cell Biochem, 2012, 113(3): 760-772.
|
| 17. |
Lee YA, Choi HM, Lee SH, et al. Hypoxia differentially affects IL-1β-stimulated MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an HIF-1α-dependent manner[J]. Rheumatology, 2012, 51(3): 443-450.
|
| 18. |
Schiltz C, Marty C, de Vernejoul MC, et al. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency[J]. J Cell Biochem, 2008, 104(5): 1803-1817.
|
| 19. |
Lewandowski KC, Komorowski J, O’Callaghan CJ, et al. Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2006, 91(3): 1173-1177.
|
| 20. |
Yang H, Liu Q, Ahn JH, et al. Luteolin downregulates IL-1β-induced MMP-9 and -13 expressions in osteoblasts via inhibition of ERK signalling pathway[J]. J Enzyme Inhib Med Chem, 2012, 27(2): 261-266.
|
